📖+10 XP
🎧+10 XP
✅+15 XP
Level A1 – BeginnerCEFR A1
2 min
76 words
- Butantan-DV is a dengue vaccine made in Brazil.
- Anvisa approved it on 26 November.
- It is for people aged 12 to 59 years.
- The vaccine needs only one dose to work.
- One dose can help reach remote Amazon communities.
- Trials in Brazil had 16,000 volunteers over nearly a decade.
- The vaccine showed 74.7% overall and 91.6% severe efficacy.
- More than 1,000,000 doses are ready for distribution.
- It will join the national programme in early 2026.
Difficult words
- vaccine — medicine that helps the body avoid disease
- approved — to say yes to a new medicine
- dose — small amount of medicine for one timedoses
- remote — far away from towns and cities
- Trials — study to test a medicine or vaccine
- volunteers — person who joins a study by choice
- efficacy — how well a medicine or vaccine works
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Would you take a vaccine that needs one dose?
- Have you visited a remote area?
Related articles
31 Dec 2025
2 Dec 2025
8 Dec 2025
14 Dec 2025
20 Dec 2025
New ultrasound method improves diagnosis of breast masses
Researchers developed a new ultrasound signal-processing method that distinguishes fluid cysts from solid breast masses. In initial patient tests doctors identified masses correctly far more often than with conventional ultrasound, which could reduce biopsies and follow-ups.